KR890003360A - 피임용 삽입관 - Google Patents

피임용 삽입관 Download PDF

Info

Publication number
KR890003360A
KR890003360A KR1019880010063A KR880010063A KR890003360A KR 890003360 A KR890003360 A KR 890003360A KR 1019880010063 A KR1019880010063 A KR 1019880010063A KR 880010063 A KR880010063 A KR 880010063A KR 890003360 A KR890003360 A KR 890003360A
Authority
KR
South Korea
Prior art keywords
contraceptive
vinyl acetate
less
eva
per
Prior art date
Application number
KR1019880010063A
Other languages
English (en)
Other versions
KR950008763B1 (en
Inventor
니스 헨드릭드
Original Assignee
에이. 지 제이. 베르메렌·에이. 디. 도우마
악조 엔. 브이
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=19850428&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=KR890003360(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by 에이. 지 제이. 베르메렌·에이. 디. 도우마, 악조 엔. 브이 filed Critical 에이. 지 제이. 베르메렌·에이. 디. 도우마
Publication of KR890003360A publication Critical patent/KR890003360A/ko
Application granted granted Critical
Publication of KR950008763B1 publication Critical patent/KR950008763B1/ko

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0092—Hollow drug-filled fibres, tubes of the core-shell type, coated fibres, coated rods, microtubules or nanotubes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Dermatology (AREA)
  • Nanotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Orthopedics, Nursing, And Contraception (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Materials For Medical Uses (AREA)
  • Prostheses (AREA)
  • Non-Silver Salt Photosensitive Materials And Non-Silver Salt Photography (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

내용 없음

Description

피임용 삽입관
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음

Claims (5)

  1. a) 용융지수가 10분에 대하여 10g 이상인 분자량을 지니고 있고 비닐 아세테이트 함량이 20중량% 또는 그 이상인 에틸렌/비닐 아세테이트 공중합체 (EVA)로 구성되며, 하루에 적어도 약 15-30μg씩 오랫동안 지속시키기에 충분한 양을 함유하는 피임 활성성분으로서 3-케토-데소게스트렐, 레보노르게스트렐 또는 게스토덴의 매트릭스 역활을 하는 코어물질과 ; b) 코어물질을 둘러싸고 있는EVA물질로 이루어지며 10분당 10g이하의 용융지수의 분자량을 지니며 20중량% 이하의 비닐 아세테이트 함량의 물을 갖는 50-250μm두께의 층의 막(membrane)으로 구성되는 최대외부 직경 약2㎜, 길이 약 5㎝ 이하의 원통형 또는 원통형과 유사한 형의 피하용 또는 국소용 피임 삽입관.
  2. 제1항에 있어서 두개의 EVA중합체의 공동축 사출에 의해 제조되는 것을 특징으로 하는 피임용 삽입관.
  3. 제1항 또는 제2항에 있어서, EVA중합체는 10분당 15-30g의 용융지수를 지니며 비닐 아세테이트 함량이 25중량% 이상인 코어물질로서 사용되는 것을 특징으로 하는 피임용 삽입관.
  4. 제1항 또는 제2항에 있어서, EVA물질은 10분당 8g 또는 그 이하의 용융지수를 지니며 비닐 아세테이트 함량이 20중량% 이하인 막 물질로서 사용되는 것을 특징으로 하는 피임용 삽입관.
  5. 제1항 또는 제2항에 있어서, 3-케토-데스트렐이 피임 성분으로 사용되는 것을 특징으로 하는 피임용 삽입관.
    ※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
KR88010063A 1987-08-08 1988-08-06 Contraceptive lmplant KR950008763B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
NL8701868 1987-08-08
NL8701868 1987-08-08

Publications (2)

Publication Number Publication Date
KR890003360A true KR890003360A (ko) 1989-04-14
KR950008763B1 KR950008763B1 (en) 1995-08-08

Family

ID=19850428

Family Applications (1)

Application Number Title Priority Date Filing Date
KR88010063A KR950008763B1 (en) 1987-08-08 1988-08-06 Contraceptive lmplant

Country Status (19)

Country Link
US (3) US4957119A (ko)
EP (1) EP0303306B1 (ko)
JP (1) JP2571831B2 (ko)
KR (1) KR950008763B1 (ko)
CN (1) CN1024753C (ko)
AT (1) ATE86484T1 (ko)
AU (1) AU603475B2 (ko)
CA (1) CA1309949C (ko)
DE (2) DE3879031T2 (ko)
DK (1) DK173166B1 (ko)
ES (1) ES2054784T3 (ko)
FI (1) FI93421C (ko)
HK (1) HK1002020A1 (ko)
IE (1) IE61730B1 (ko)
MX (1) MX9203817A (ko)
NL (1) NL980027I2 (ko)
NZ (1) NZ225399A (ko)
PT (1) PT88220B (ko)
ZA (1) ZA885034B (ko)

Families Citing this family (95)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5114719A (en) * 1987-04-29 1992-05-19 Sabel Bernhard A Extended drug delivery of small, water-soluble molecules
US5156164A (en) * 1988-10-13 1992-10-20 Leveen Harry H Iodine contraceptive sponge
BE1002600A3 (fr) * 1988-11-23 1991-04-09 Wildemeersch Dirk Dispositif intra-uterin perfectionne.
IE71202B1 (en) * 1990-12-17 1997-02-12 Akzo Nv Progestagen-only contraceptive
WO1993017662A1 (en) * 1992-03-02 1993-09-16 Daratech Pty. Ltd. Improved implants
ES2150427T3 (es) * 1992-06-02 2000-12-01 Bard Inc C R Procedimiento y dispositivo de implante para el suministro de farmacos a largo plazo.
US5368588A (en) * 1993-02-26 1994-11-29 Bettinger; David S. Parenteral fluid medication reservoir pump
US5443461A (en) * 1993-08-31 1995-08-22 Alza Corporation Segmented device for simultaneous delivery of multiple beneficial agents
US5681817A (en) 1994-02-04 1997-10-28 The Medical College Of Hampton Roads Treatment of ovarian estrogen dependent conditions
US5660848A (en) * 1994-11-02 1997-08-26 The Population Council, Center For Biomedical Research Subdermally implantable device
US5521166A (en) * 1994-12-19 1996-05-28 Ortho Pharmaceitical Corporation Antiprogestin cyclophasic hormonal regimen
DE19539361A1 (de) * 1995-10-23 1997-04-24 Basf Ag Verfahren zur Herstellung von mehrschichtigen, festen Arzneiformen zur oralen oder rektalen Verabreichung
US5733565A (en) * 1996-02-23 1998-03-31 The Population Council, Center For Biomedical Research Male contraceptive implant
CN1088993C (zh) * 1996-10-11 2002-08-14 上海市计划生育科学研究所 含孕二烯酮的长效皮下避孕埋植剂
US6203813B1 (en) 1997-01-13 2001-03-20 Lance L. Gooberman Pharmaceutical delivery device and method of preparation therefor
TW358031B (en) * 1997-04-11 1999-05-11 Akze Nobel N V Drug delivery system for 2 or more active substances
DE19744135C1 (de) * 1997-09-29 1999-03-25 Schering Ag Beschichtete medizinische Implantate, Verfahren zu ihrer Herstellung und ihre Verwendung zur Restenoseprophylaxe
CA2331132C (en) 1998-05-01 2008-12-16 Fei Enterprises, Ltd. Method for injection molding manufacture of controlled release devices
US6117441A (en) * 1998-07-02 2000-09-12 The Population Council, Inc. Silicone core long term androgen delivery implant
AU4957999A (en) * 1998-07-17 2000-02-07 Pharmacia & Upjohn Company Subcutaneous medroxyprogesterone acetate for contraception
US6063395A (en) * 1998-11-12 2000-05-16 Leiras Oy Drug delivery device especially for the delivery of progestins and estrogens
US6117442A (en) * 1998-11-12 2000-09-12 Leiras Oy Drug delivery device, especially for the delivery of androgens
US6217895B1 (en) 1999-03-22 2001-04-17 Control Delivery Systems Method for treating and/or preventing retinal diseases with sustained release corticosteroids
CA2267743C (en) * 1999-03-30 2011-07-26 Robert F. Casper Low dose estrogen interrupted hormone replacement therapy
US6375972B1 (en) 2000-04-26 2002-04-23 Control Delivery Systems, Inc. Sustained release drug delivery devices, methods of use, and methods of manufacturing thereof
IL153648A0 (en) * 2000-08-23 2003-07-06 Akzo Nobel Nv Novel testosterone ester formulation for human use
US7776310B2 (en) 2000-11-16 2010-08-17 Microspherix Llc Flexible and/or elastic brachytherapy seed or strand
WO2002092054A2 (en) * 2001-05-11 2002-11-21 Ortho-Mcneil Pharmaceutical, Inc. Immune modulation device for use in animals
HUP0400390A2 (hu) 2001-07-02 2004-09-28 Akzo Nobel N.V. Tetrahidrokinolin-származékok és ezeket tartalmazó gyógyszerkészítmények
KR20040036928A (ko) * 2001-08-31 2004-05-03 쉐링 오와이 약물 전달 시스템
TWI228508B (en) 2001-09-04 2005-03-01 Akzo Nobel Nv Thieno[2,3-d]pyrimidines with combined LH and FSH agonistic activity
NZ531375A (en) 2001-09-04 2005-06-24 Akzo Nobel Nv Glycine-substituted thieno [2,3-d]pyrimidines with combined LH and FSH agonistic activity may be used to treat fertility disorders
BR0307218A (pt) * 2002-01-24 2004-12-07 Smart Drug Systems Inc Composição farmacêutica com liberação prolongada
CN1652799A (zh) * 2002-03-11 2005-08-10 詹森药业有限公司 只用抑制硫酸酯酶的孕激素的避孕给药方案
TWI297685B (en) 2002-04-04 2008-06-11 Organon Nv Non-steroidal progesterone receptor modulators
US8871241B2 (en) * 2002-05-07 2014-10-28 Psivida Us, Inc. Injectable sustained release delivery devices
AU2003234439A1 (en) * 2002-05-07 2003-11-11 Control Delivery Systems, Inc. Processes for forming a drug delivery device
PT2561860T (pt) * 2002-05-31 2018-05-08 Titan Pharmaceuticals Inc Dispositivo polimérico implantável para a libertação prolongada de buprenorfina
ES2277139T3 (es) * 2002-08-28 2007-07-01 Robert Casper Regimen de reposicion de estrogenos.
KR20050072812A (ko) 2002-11-07 2005-07-12 악조 노벨 엔.브이. 안드로겐-수용체와 관련된 질병의 치료에 효과적인 인돌
TWI322012B (en) 2002-12-20 2010-03-21 Organon Nv Tetrahydroquinoline derivatives
TWI306855B (en) 2002-12-20 2009-03-01 Organon Nv Tetrahydroquinoline derivatives
EP1610791B1 (en) * 2003-03-31 2011-02-23 Titan Pharmaceuticals, Inc. Implantable polymeric device for sustained release of dopamine agonist
DE602004026173D1 (de) 2003-04-29 2010-05-06 Gen Hospital Corp Verfahren und vorrichtungen für die verzögerte freisetzung von mehreren arzneimitteln
TWI336627B (en) 2003-05-23 2011-02-01 Organon Nv Drug delivery system,and use and manufacturing method thereof
MXPA05012768A (es) * 2003-05-30 2006-02-22 Titan Pharmaceuticals Inc Dispositivo polimerico implantable para liberacion prolongada de nalmefeno.
AU2004249295A1 (en) * 2003-06-20 2004-12-29 Viral Genomix, Inc. Compositions for and methods for treating HIV
US7976847B2 (en) * 2004-01-13 2011-07-12 Vasogenix Pharmaceuticals, Inc. Controlled release CGRP delivery composition for cardiovascular and renal indications
WO2005070445A2 (en) * 2004-01-13 2005-08-04 Vasogenix Pharmaceuticals, Inc. Methods for treating acute myocardial infarction by calcitonin gene related peptide and compositions containing the same
CA2552757A1 (en) * 2004-01-13 2005-08-04 Vasogenix Pharmaceuticals, Inc. Methods of using cgrp for cardiovascular and renal indications
TWI434676B (zh) 2004-03-19 2014-04-21 Merck Sharp & Dohme 可用ｘ射線看出之藥物遞送裝置
TW200531977A (en) 2004-03-25 2005-10-01 Akzo Nobel Nv Progesterone receptor modulators
TW200602317A (en) 2004-04-23 2006-01-16 Akzo Nobel Nv Novel androgens
DK1629844T4 (da) 2004-07-13 2012-05-29 Bayer Schering Pharma Oy Retarderet indgivelsessystem med kontrolleret initialudbrud
WO2006078320A2 (en) 2004-08-04 2006-07-27 Brookwood Pharmaceuticals, Inc. Methods for manufacturing delivery devices and devices thereof
US11246913B2 (en) 2005-02-03 2022-02-15 Intarcia Therapeutics, Inc. Suspension formulation comprising an insulinotropic peptide
AU2006259368A1 (en) 2005-06-15 2006-12-28 Hydra Biosciences, Inc. Modulators of sperm hypermotility and uses thereof
EP1743638A1 (en) 2005-07-15 2007-01-17 Laboratorios Del Dr. Esteve, S.A. Pharmaceutical formulations of substituted pyrazoline compounds
US7682356B2 (en) 2006-08-09 2010-03-23 Intarcia Therapeutics, Inc. Osmotic delivery systems and piston assemblies for use therein
US7989442B2 (en) 2006-09-27 2011-08-02 N.V. Organon Progesterone receptor modulators
CN101209238B (zh) * 2006-12-27 2012-05-09 辽宁省计划生育科学研究院 含孕二烯酮的生物降解型长效皮下避孕埋植剂及其制备
JP5351884B2 (ja) 2007-04-23 2013-11-27 インターシア セラピューティクス，インコーポレイティド インスリン分泌促進性ペプチドの懸濁製剤及び使用
US8063037B2 (en) 2007-05-07 2011-11-22 N. V. Organon Progesterone receptor modulators
CN101130057B (zh) * 2007-07-06 2011-04-27 复旦大学 胸腺五肽长效植入剂及其制备方法
TW200930343A (en) 2007-09-21 2009-07-16 Organon Nv Drug delivery system
EP2227252B1 (en) * 2007-11-27 2012-07-25 Nira Hochman Adjuvant comprising vaccinium macrocarpon
US8728528B2 (en) 2007-12-20 2014-05-20 Evonik Corporation Process for preparing microparticles having a low residual solvent volume
CA2726861C (en) 2008-02-13 2014-05-27 Intarcia Therapeutics, Inc. Devices, formulations, and methods for delivery of multiple beneficial agents
HUE035862T2 (en) 2009-09-28 2018-05-28 Intarcia Therapeutics Inc Rapid development and / or completion of substantially steady-state drug delivery
CA2785468A1 (en) * 2009-12-23 2011-06-30 Psivida Us, Inc. Sustained release delivery devices
US20120208755A1 (en) 2011-02-16 2012-08-16 Intarcia Therapeutics, Inc. Compositions, Devices and Methods of Use Thereof for the Treatment of Cancers
US10028858B2 (en) 2011-07-11 2018-07-24 Medicines360 Intrauterine systems, IUD insertion devices, and related methods and kits therefor
AR089765A1 (es) * 2012-01-23 2014-09-17 Bayer Oy Un sistema para el suministro de un farmaco
US10154856B2 (en) 2013-02-06 2018-12-18 Mark SILLENDER Therapeutic substance transfer catheter and method
AU2014214538B2 (en) 2013-02-06 2018-11-15 Mark SILLENDER Embryo transfer catheter and method
US10413504B2 (en) 2013-12-11 2019-09-17 Merck Sharp & Dohme Corp. Intravaginal ring drug delivery system
US10596103B2 (en) 2013-12-11 2020-03-24 Merek Sharp & Dohme B.V. Drug delivery system for delivery of anti-virals
US9889085B1 (en) 2014-09-30 2018-02-13 Intarcia Therapeutics, Inc. Therapeutic methods for the treatment of diabetes and related conditions for patients with high baseline HbA1c
WO2016149561A1 (en) * 2015-03-17 2016-09-22 Oak Crest Institute Of Science Subdermal implants for the sustained delivery of water-soluble drugs
ES2968262T3 (es) 2015-06-03 2024-05-08 I2O Therapeutics Inc Sistemas de colocación de implantes
WO2017200943A1 (en) 2016-05-16 2017-11-23 Intarcia Therapeutics, Inc. Glucagon-receptor selective polypeptides and methods of use thereof
USD860451S1 (en) 2016-06-02 2019-09-17 Intarcia Therapeutics, Inc. Implant removal tool
USD840030S1 (en) 2016-06-02 2019-02-05 Intarcia Therapeutics, Inc. Implant placement guide
WO2018064544A1 (en) 2016-09-29 2018-04-05 Gesea Biosciences Inc. Bioerodible contraceptive implant and methods of use thereof
CN110225762A (zh) 2017-01-03 2019-09-10 因塔西亚制药公司 包括glp-1受体激动剂的连续施用和药物的共同施用的方法
US11571328B2 (en) 2018-04-09 2023-02-07 Medicines360 IUD insertion devices
WO2019226516A1 (en) 2018-05-24 2019-11-28 Celanese EVA Performance Polymers Corporation Implantable device for sustained release of a macromolecular drug compound
JP2021524840A (ja) * 2018-05-24 2021-09-16 セラニーズ・イーブイエイ・パフォーマンス・ポリマーズ・エルエルシー 高分子薬剤化合物の持続放出用の埋め込み型デバイス
US20200261258A1 (en) 2019-02-19 2020-08-20 Medicines360 Devices, systems, methods and kits for insertion and removal of iuds
BR102020007749A2 (pt) 2020-04-17 2021-11-03 Edson Luiz Peracchi Implante subcutâneo reabsorvível de longa duração com liberação controlada de substância farmacologicamente ativa pré-concentrada em polímero para tratamento da endometriose
BR102020010923A2 (pt) 2020-05-29 2021-12-14 Luiz Peracchi Edson Implante subcutâneo reabsorvível de longa duração com liberação prolongada de substância farmacologicamente ativa pré-concentrada em polímero para tratamento da insuficiência adrenal crônica ou hipocortisolismo
BR102020013862A2 (pt) 2020-07-07 2022-01-18 Edson Luiz Peracchi Implante subcutâneo reabsorvível de longa duração com liberação sustentada de substância farmacologicamente ativa pré-concentrada em polímero para tratamento da doença de parkinson
WO2022204771A1 (pt) 2021-03-29 2022-10-06 Edson Luiz Peracchi Implante subcutâneo reabsorvível de longa duração com liberação prolongada de substância farmacologicamente ativa pré-concentrada em polímero para tratamento do hipotireoidismo e processo
CN113209050A (zh) * 2021-05-14 2021-08-06 浙江恒冀制药有限责任公司 基于生物相容性聚合物的长效体内皮埋或内植缓释制剂
GB202401392D0 (en) 2024-02-02 2024-03-20 Imphatec Ltd Implant for delivery of a drug

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3903880A (en) * 1972-08-17 1975-09-09 Alza Corp Intrauterine device for managing the reproductive process
US3926188A (en) * 1974-11-14 1975-12-16 Alza Corp Laminated drug dispenser
US4582052A (en) * 1982-03-23 1986-04-15 Repromed, Inc. Povidone-iodine dispensing fiber
NZ200564A (en) * 1982-05-10 1987-03-06 Ahi Operations Ltd Device for slowly releasing chemicals into body cavities of animals
US4601714A (en) * 1983-07-07 1986-07-22 Burnhill Michael S Vaginal device
US4629621A (en) * 1984-07-23 1986-12-16 Zetachron, Inc. Erodible matrix for sustained release bioactive composition
US4596576A (en) * 1984-10-12 1986-06-24 Akzo N.V. Release system for two or more active substances
US4720384A (en) * 1985-05-03 1988-01-19 E. I. Du Pont De Nemours And Company Manufacture of hollow fine tubular drug delivery systems
US4673565A (en) * 1985-05-03 1987-06-16 E. I. Du Pont De Nemours And Company Pharmaceutical compositions containing hollow fine tubular drug delivery systems

Also Published As

Publication number Publication date
DE3879031D1 (de) 1993-04-15
AU603475B2 (en) 1990-11-15
PT88220B (pt) 1995-03-01
IE882118L (en) 1989-02-08
FI883594A (fi) 1989-02-09
KR950008763B1 (en) 1995-08-08
ATE86484T1 (de) 1993-03-15
DE3879031T2 (de) 1993-06-24
NL980027I1 (nl) 1998-12-01
IE61730B1 (en) 1994-11-30
EP0303306B1 (en) 1993-03-10
DK438688D0 (da) 1988-08-05
US5150718A (en) 1992-09-29
NL980027I2 (nl) 1999-02-01
DK438688A (da) 1989-02-09
FI93421C (fi) 1995-04-10
PT88220A (pt) 1989-06-30
DK173166B1 (da) 2000-02-28
FI883594A0 (fi) 1988-08-01
HK1002020A1 (en) 1998-07-24
JPS6470410A (en) 1989-03-15
ZA885034B (en) 1989-03-29
JP2571831B2 (ja) 1997-01-16
CN1024753C (zh) 1994-06-01
MX9203817A (es) 1992-08-01
FI93421B (fi) 1994-12-30
US4957119A (en) 1990-09-18
ES2054784T3 (es) 1994-08-16
AU2044988A (en) 1989-03-02
DE19975054I2 (de) 2000-04-13
NZ225399A (en) 1990-09-26
CN1031323A (zh) 1989-03-01
EP0303306A1 (en) 1989-02-15
CA1309949C (en) 1992-11-10
US5088505A (en) 1992-02-18

Similar Documents

Publication Publication Date Title
KR890003360A (ko) 피임용 삽입관
RU2226387C2 (ru) Устройство для доставки лекарственных средств, особенно для доставки прогестинов и эстрогенов
US4596576A (en) Release system for two or more active substances
AU1234988A (en) Pharmaceutical delivery device
AU3674295A (en) Stent for liberating drug
KR910007508A (ko) 서방출 드레싱용 제제 및 이의 용도
DE69332222T2 (de) Enythropoietin enthaltendes arzneimittelabgabesystem
ES2053882T3 (es) Metodo para reducir la irritacion de la piel asociado con composiciones potenciadoras de penetracion del farmaco.
AU681452B2 (en) Pernasal composition and pernasal preparation containing thesame
PL289322A1 (en) Method of obtaining a composition of controllable release of medicine contained therein
NO872381D0 (no) Fremgangsmaate for fremstilling av langsomt frigivende preparater.
AU7004194A (en) Drug system
NO920832D0 (no) Faststoffmatrikssystem for transdermal medikamentavlevering
RU2226388C2 (ru) Устройство для доставки лекарственного средства, особенно для доставки андрогенов
KR900007424A (ko) 세포보호성 약제로서의 n-아세틸글루코사민의 사용방법 및 그 조성물
KR930701209A (ko) 신경 이식 시스템
RU2001116118A (ru) Устройство для доставки лекарственного средства, особенно для доставки андрогенов
EP0325086A3 (en) Novel methods for obtaining therapeutic systems with controlled release of the drug
AU1018292A (en) Preparation of homogeneous hydrogel copolymers
KR880007062A (ko) 수성 약제학적 조성물
Hughes et al. Gentamicin Resistance Plasmids in Hospital Infections.
EP0416722A3 (en) Pharmaceutical compositions having differential drug release rate

Legal Events

Date Code Title Description
A201 Request for examination
G160 Decision to publish patent application
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 20090803

Year of fee payment: 15

EXPY Expiration of term